Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Head and Neck Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Radiation Injuries 2Xerostomia 1Uterine Cervical Neoplasms 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Multiple Myeloma 1Mucositis 1Deglutition Disorders 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

Radiotherapy 7Cisplatin 6Fibroblast Growth Factor 7 3Water 2Radiation 2Low-Level Light Therapy 2Injections 2peppermint oil 1pegfilgrastim 1oxycodone-acetaminophen 1kang-lai-te 1cyclohexaneacetic acid 1brilacidin 1anise oil 1acetaminophen, hydrocodone drug combination 1Xylitol 1Tramadol 1Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sorbic Acid 1Selenomethionine 1Saline Solution 1RRx-001 1Poloxamer 1Phosphatidylinositol 3-Kinases 1Pain Management 1Neck Dissection 1Methods 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mucositis × Amifostine × Clear all
NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
41 enrolled 12 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡